UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:MTCH2-FHIT |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: MTCH2-FHIT | FusionPDB ID: 55562 | FusionGDB2.0 ID: 55562 | Hgene | Tgene | Gene symbol | MTCH2 | FHIT | Gene ID | 23788 | 2272 |
Gene name | mitochondrial carrier 2 | fragile histidine triad diadenosine triphosphatase | |
Synonyms | HSPC032|MIMP|SLC25A50 | AP3Aase|FRA3B | |
Cytomap | 11p11.2 | 3p14.2 | |
Type of gene | protein-coding | protein-coding | |
Description | mitochondrial carrier homolog 22310034D24Rikmet-induced mitochondrial proteinsolute carrier family 25, member 50 | bis(5'-adenosyl)-triphosphataseAP3A hydrolasediadenosine 5',5'''-P1,P3-triphosphate hydrolasedinucleosidetriphosphatase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9Y6C9 | P49789 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000302503, ENST00000542981, ENST00000534074, | ENST00000341848, ENST00000466788, ENST00000468189, ENST00000476844, ENST00000492590, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 8 X 7 X 4=224 | 27 X 20 X 11=5940 |
# samples | 9 | 32 | |
** MAII score | log2(9/224*10)=-1.31550182572793 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(32/5940*10)=-4.21431912080077 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: MTCH2 [Title/Abstract] AND FHIT [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MTCH2(47660251)-FHIT(59738047), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | MTCH2-FHIT seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MTCH2-FHIT seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FHIT | GO:0006163 | purine nucleotide metabolic process | 9323207 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | OV | TCGA-23-2077-01A | MTCH2 | chr11 | 47660251 | - | FHIT | chr3 | 59738047 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000302503 | MTCH2 | chr11 | 47660251 | - | ENST00000476844 | FHIT | chr3 | 59738047 | - | 797 | 437 | 29 | 532 | 167 |
ENST00000302503 | MTCH2 | chr11 | 47660251 | - | ENST00000492590 | FHIT | chr3 | 59738047 | - | 808 | 437 | 29 | 532 | 167 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000302503 | ENST00000476844 | MTCH2 | chr11 | 47660251 | - | FHIT | chr3 | 59738047 | - | 0.029282987 | 0.97071695 |
ENST00000302503 | ENST00000492590 | MTCH2 | chr11 | 47660251 | - | FHIT | chr3 | 59738047 | - | 0.037373826 | 0.9626262 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >55562_55562_1_MTCH2-FHIT_MTCH2_chr11_47660251_ENST00000302503_FHIT_chr3_59738047_ENST00000476844_length(amino acids)=167AA_BP=136 MLRACARAAGGPVKPAALARDLGPAHRVAWWLRLSVRPPAGAIMADAASQVLLGSGLTILSQPLMYVKVLIQVGYEPLPPTIGRNIFGRQ -------------------------------------------------------------- >55562_55562_2_MTCH2-FHIT_MTCH2_chr11_47660251_ENST00000302503_FHIT_chr3_59738047_ENST00000492590_length(amino acids)=167AA_BP=136 MLRACARAAGGPVKPAALARDLGPAHRVAWWLRLSVRPPAGAIMADAASQVLLGSGLTILSQPLMYVKVLIQVGYEPLPPTIGRNIFGRQ -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:47660251/chr3:59738047) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
MTCH2 | FHIT |
FUNCTION: The substrate transported is not yet known. Induces mitochondrial depolarization. | FUNCTION: Possesses dinucleoside triphosphate hydrolase activity (PubMed:12574506, PubMed:15182206, PubMed:8794732, PubMed:9323207, PubMed:9576908, PubMed:9543008). Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP (PubMed:12574506, PubMed:15182206, PubMed:8794732, PubMed:9323207, PubMed:9576908, PubMed:9543008). Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP (PubMed:8794732). Exhibits adenylylsulfatase activity, hydrolyzing adenosine 5'-phosphosulfate to yield AMP and sulfate (PubMed:18694747). Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2 (PubMed:18694747). Exhibits adenylylsulfate-ammonia adenylyltransferase, catalyzing the ammonolysis of adenosine 5'-phosphosulfate resulting in the formation of adenosine 5'-phosphoramidate (PubMed:26181368). Also catalyzes the ammonolysis of adenosine 5-phosphorofluoridate and diadenosine triphosphate (PubMed:26181368). Modulates transcriptional activation by CTNNB1 and thereby contributes to regulate the expression of genes essential for cell proliferation and survival, such as CCND1 and BIRC5 (PubMed:18077326). Plays a role in the induction of apoptosis via SRC and AKT1 signaling pathways (PubMed:16407838). Inhibits MDM2-mediated proteasomal degradation of p53/TP53 and thereby plays a role in p53/TP53-mediated apoptosis (PubMed:15313915). Induction of apoptosis depends on the ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or related compounds, but does not require its catalytic activity, it may in part come from the mitochondrial form, which sensitizes the low-affinity Ca(2+) transporters, enhancing mitochondrial calcium uptake (PubMed:12574506, PubMed:19622739). Functions as tumor suppressor (By similarity). {ECO:0000250|UniProtKB:O89106, ECO:0000269|PubMed:12574506, ECO:0000269|PubMed:15313915, ECO:0000269|PubMed:16407838, ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:18694747, ECO:0000269|PubMed:19622739, ECO:0000269|PubMed:26181368, ECO:0000269|PubMed:8794732, ECO:0000269|PubMed:9323207, ECO:0000269|PubMed:9543008}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MTCH2 | chr11:47660251 | chr3:59738047 | ENST00000302503 | - | 3 | 13 | 8_28 | 93.0 | 304.0 | Transmembrane | Helical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MTCH2 | chr11:47660251 | chr3:59738047 | ENST00000302503 | - | 3 | 13 | 118_206 | 93.0 | 304.0 | Repeat | Note=Solcar 2 |
Hgene | MTCH2 | chr11:47660251 | chr3:59738047 | ENST00000302503 | - | 3 | 13 | 2_98 | 93.0 | 304.0 | Repeat | Note=Solcar 1 |
Hgene | MTCH2 | chr11:47660251 | chr3:59738047 | ENST00000302503 | - | 3 | 13 | 175_195 | 93.0 | 304.0 | Transmembrane | Helical |
Hgene | MTCH2 | chr11:47660251 | chr3:59738047 | ENST00000302503 | - | 3 | 13 | 224_244 | 93.0 | 304.0 | Transmembrane | Helical |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000341848 | 3 | 5 | 2_109 | 116.0 | 148.0 | Domain | HIT | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000468189 | 7 | 9 | 2_109 | 116.0 | 148.0 | Domain | HIT | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000476844 | 7 | 10 | 2_109 | 116.0 | 214.0 | Domain | HIT | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000492590 | 7 | 10 | 2_109 | 116.0 | 205.33333333333334 | Domain | HIT | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000341848 | 3 | 5 | 94_98 | 116.0 | 148.0 | Motif | Histidine triad motif | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000468189 | 7 | 9 | 94_98 | 116.0 | 148.0 | Motif | Histidine triad motif | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000476844 | 7 | 10 | 94_98 | 116.0 | 214.0 | Motif | Histidine triad motif | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000492590 | 7 | 10 | 94_98 | 116.0 | 205.33333333333334 | Motif | Histidine triad motif | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000341848 | 3 | 5 | 89_92 | 116.0 | 148.0 | Nucleotide binding | Substrate | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000468189 | 7 | 9 | 89_92 | 116.0 | 148.0 | Nucleotide binding | Substrate | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000476844 | 7 | 10 | 89_92 | 116.0 | 214.0 | Nucleotide binding | Substrate | |
Tgene | FHIT | chr11:47660251 | chr3:59738047 | ENST00000492590 | 7 | 10 | 89_92 | 116.0 | 205.33333333333334 | Nucleotide binding | Substrate |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
FHIT | FHIT, UBE2I, CTNNB1, LEF1, TRIM23, RAB40B, MDM2, REL, TP53, ARHGAP19, MTMR6, RABL2A, CHEK1, DDIT4L, SPERT, FDCSP, GAST, GGH, BCAS2, PRPF6, YTHDF1, Rbm14, |
![]() |
Gene | STRING network |
MTCH2 | |
FHIT | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to MTCH2-FHIT |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to MTCH2-FHIT |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | FHIT | C0024121 | Lung Neoplasms | 2 | CTD_human |
Tgene | FHIT | C0025500 | Mesothelioma | 2 | CTD_human |
Tgene | FHIT | C0242379 | Malignant neoplasm of lung | 2 | CTD_human |
Tgene | FHIT | C0007097 | Carcinoma | 1 | CTD_human |
Tgene | FHIT | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | FHIT | C0013146 | Drug abuse | 1 | CTD_human |
Tgene | FHIT | C0013170 | Drug habituation | 1 | CTD_human |
Tgene | FHIT | C0013222 | Drug Use Disorders | 1 | CTD_human |
Tgene | FHIT | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | FHIT | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Tgene | FHIT | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Tgene | FHIT | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | FHIT | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | FHIT | C0038580 | Substance Dependence | 1 | CTD_human |
Tgene | FHIT | C0038586 | Substance Use Disorders | 1 | CTD_human |
Tgene | FHIT | C0042076 | Urologic Neoplasms | 1 | CTD_human |
Tgene | FHIT | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
Tgene | FHIT | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
Tgene | FHIT | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
Tgene | FHIT | C0205699 | Carcinomatosis | 1 | CTD_human |
Tgene | FHIT | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
Tgene | FHIT | C0236804 | Amphetamine Addiction | 1 | CTD_human |
Tgene | FHIT | C0236807 | Amphetamine Abuse | 1 | CTD_human |
Tgene | FHIT | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Tgene | FHIT | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Tgene | FHIT | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Tgene | FHIT | C0740858 | Substance abuse problem | 1 | CTD_human |
Tgene | FHIT | C0751571 | Cancer of Urinary Tract | 1 | CTD_human |
Tgene | FHIT | C1510472 | Drug Dependence | 1 | CTD_human |
Tgene | FHIT | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Tgene | FHIT | C4316881 | Prescription Drug Abuse | 1 | CTD_human |